A tiny diabetes drug maker in Norway decided to get into energy trading — and failed spectacularly

Vistin Pharma, known for its type-2 diabetes drug Metformin, said in March that it would try its hand at the energy market. Things didn't go to plan.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BusinessInsider /  🏆 729. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Norway Embarks On Its Most Ambitious Transport Project YetNorway's rugged west coast features glaciers, waterfalls and fjords that are beautiful — but take a long time to navigate. A major infrastructure plan could cut travel time in half.
Read more »

Norway Supreme Court to hear snow crab case with implication for oilNorway's Supreme Court will on Tuesday hear arguments on whether EU ships c...
Read more »

Norway police probe Jay-Z's Tidal over listening numbersNorwegian police said on Monday they were investigating allegations that some listening numbers at Tidal Music, owned by Jay-Z, Beyonce and other stars, were artificially inflated. Tidal, which began life as Norwegian start-up Wimp, has previously dismissed the allegations and its lawyer Fredrik Berg
Read more »